TipRanks
Go Ultimate55% OFF

Sprint Bioscience AB (SPRINT) Balance Sheet

Sprint Bioscience AB Balance Sheet

Sprint Bioscience AB's total assets for Q2 2026 were $104.28M, a decrease of 12.35% from the previous quarter. SE:SPRINT total liabilities were $14.20M for the fiscal quarter, a 11.92% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 136.66M$ 42.05M$ 62.38M$ 37.42M$ 79.14M
$ 17.48M$ 32.78M$ 34.60M$ 9.23M$ 8.68M
$ 119.18M$ 9.27M$ 27.77M$ 28.19M$ 70.45M

Currency in SEK

Sprint Bioscience AB Debt to Assets

050M100M150M0 %30 %60 %90 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets